Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Alkermes plc - Ordinary Shares (NQ:ALKS)

34.01 +0.49 (+1.46%)
Streaming Delayed Price Updated: 11:35 AM EST, Jan 28, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Alkermes plc - Ordinary Shares

< Previous 1 2
...
5 6 7 8 9 10 11 12 Next >
News headline image
10 Biggest Price Target Changes For Thursday ↗
Oppenheimer lowered Teladoc Health, Inc. (NYSE:TDOC 
Via Benzinga
News headline image
Alkermes plc (ALKS) Q3 2021 Earnings Call Transcript ↗
ALKS earnings call for the period ending September 30, 2021. 
Via The Motley Fool
Topics Earnings
Ketamine’s Potential As A Treatment For Depression Has Drawn Major Industry Attention
Palm Beach, FL –October 27, 2021 – FinancialNewsMedia.com News Commentary – Among the race to see what psychedelic drugs can do, ketamine is a step ahead of all other drugs, because it has already been... 
Via FinancialNewsMedia
News headline image
Wellness Tips for Cancer Patients
SOURCE: Alkermes 
Via 3BL Media
News headline image
Cyber Currency ↗
Canadian stocks are particularly buoyant and not just in energy which is a riser today because the loony is up against the buck. 
Via Talk Markets
News headline image
The Week Ahead In Biotech (Oct. 24-30): Eyenovia, ANI Pharma, Clearside Medical FDA Decisions, Merck, Bristol-Myers Squibb Earnings, IPOs And More ↗
Biotech stocks posted gains for the second week running, supported by multiple catalysts that included a good start to the big pharma reporting season and broader market strength... 
Via Benzinga
News headline image
Wednesday Market Coverage ↗
Today gold rose again despite the active market for bitcoin and the lower Chinese demand for mine products like iron and coal. 
Via Talk Markets
News headline image
Beam Therapeutics Stock Flashes Renewed Technical Strength ↗
On Tuesday, Beam Therapeutics stock reached an key performance benchmark, seeing its RS Rating jump to 92, up from 88 the day before. 
Via Investor's Business Daily
News headline image
Innoviva Stock In Buy Range; Joins Ranks Of Top-Performing Stocks With Strength Ratings Over 90 ↗
Innoviva stock is within a buy range after climbing above a 16.82 entry in a flat base. The proper buying range is up to 5% above the entry. 
Via Investor's Business Daily
News headline image
Alkermes Stock Composite Rating Rises To Near-Perfect 96 As It Posts Erratic But Huge Sales Gains ↗
The IBD SmartSelect Composite Rating for Alkermes rose from 94 to 96 Tuesday. 
Via Investor's Business Daily
News headline image
The Daily Biotech Pulse: Allogene Sinks On FDA Clinical Hold, Takeda Gets Adcom Backing, Quidel Reports Q3 COVID Revenues, IPOs ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 7) Alkermes plc (NASDAQ: ALKS)... 
Via Benzinga
News headline image
Arcturus Therapeutics Stock Sees Relative Strength Rating Rise To 83 ↗
Arcturus Therapeutics sees its Relative Strength Rating hit the 80-plus level. 
Via Investor's Business Daily
News headline image
The Daily Biotech Pulse: AbbVie's Migraine Drug OK'd By FDA, Amicus Spins Off Gene Therapy Business, Geovax In-Licenses Cancer Drug ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. Click here for accessing Benzinga's FDA Calendar Scaling The Peaks (Biotech Stocks... 
Via Benzinga
News headline image
Ligand Pharmaceuticals Stock Shows Rising Price Performance ↗
A Relative Strength Rating upgrade for San Diego-based Ligand Pharmaceuticals stock shows improving technical performance. 
Via Investor's Business Daily
News headline image
Acceleron Pharma Stock Meets 80-Plus Relative Strength Rating Benchmark ↗
Want to build a watch list? Focus on stocks with an 80-plus RS Rating. Acceleron Pharma stock cleared that benchmark with an upgrade to 83. 
Via Investor's Business Daily
News headline image
Inmune Bio Stock Flashes Robust RS Rating ↗
On Wednesday, Inmune Bio stock saw its Relative Strength Rating jump into the 90-plus percentile, to 92 from 85 the day before. 
Via Investor's Business Daily
News headline image
New Survey Provides Insights Into Drinking Behaviors During the Pandemic
SOURCE: Alkermes 
Via 3BL Media
News headline image
Recovery Month Renews Focus on Diagnosis, Treatment of Substance Use Disorder
SOURCE: Alkermes 
Via 3BL Media
Topics Death
News headline image
Ligand Pharmaceuticals Stock Shows Market Leadership With Jump To 82 RS Rating ↗
Ligand Pharmaceuticals stock saw a positive improvement to its Relative Strength (RS) Rating on Monday, rising from 71 to 82. 
Via Investor's Business Daily
News headline image
I-Mab Stock Joins Rank Of Stocks With RS Ratings Over 90 ↗
Looking for the best stocks to buy? Focus on those with rising relative strength such as I-Mab stock, which saw a (RS) Rating upgrade to 93. 
Via Investor's Business Daily
News headline image
Alkermes Associate Director Discusses How Her Personal Journey With Ovarian Cancer Influences Her Work
SOURCE: Alkermes 
Via 3BL Media
News headline image
Alkermes Announces Launch of 4th Annual Alkermes Pathways Research Awards® Program
SOURCE: Alkermes 
Via 3BL Media
News headline image
Benzinga's Bulls And Bears Of The Week: Alibaba, Apple, Nio, PayPal, Verizon And More ↗
Benzinga has examined the prospects for many investor 
Via Benzinga
News headline image
BofA Downgrades Alkermes After Stock Rally: 'We Don't See A Favorable Catalyst Pathway' ↗
Following the recent rally, Alkermes Plc’s (NASDAQ:ALKS 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For September 2, 2021 ↗
Upgrades For Okta Inc (NASDAQ: 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
Gainers Plus Therapeutics (NASDAQ:PSTV) shares increased by 22.1% to $2.32 during Thursday's pre-market session. The company's market cap stands at $28.0 million.... 
Via Benzinga
News headline image
Alkermes Sr. Director of Oncology Discusses Career, Inspirational Women in STEM
SOURCE: Alkermes 
Via 3BL Media
News headline image
The Daily Biotech Pulse: Merck Releases Twin Dose Of Positive Tidings, Astellas Voluntarily Pauses Gene Therapy Study, Ascendis Offering ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 31) AC Immune SA (NASDAQ: ACIU... 
Via Benzinga
News headline image
The Daily Biotech Pulse: VectivBio In M&A Mix, Sonnet Biotherapeutics Advances Candidate To Clinics, CEO Transitions At Galapagos, Talis Biomedical ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 26) Agenus Inc. (NASDAQ: AGEN)... 
Via Benzinga
News headline image
The Daily Biotech Pulse: MorphoSys-Incyte Snag European Nod, Immutep Granted Chinese Patent, Bolt Biotherapeutics Strike Oncology Collaboration ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 26) Agenus Inc. (NASDAQ: AGEN)... 
Via Benzinga
Topics Intellectual Property
< Previous 1 2
...
5 6 7 8 9 10 11 12 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.